Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Efficacy of antidepressants: bias in randomized clinical trials and related issues

Wang, Sheng-Min, Han, Changsu, Lee, Soo-Jung, Jun, Tae-Youn, Patkar, Ashwin A., Masand, Prakash S., Pae, Chi-Un · 2018 · Expert Review of Clinical Pharmacology

Abstract

Introduction Countless antidepressant randomized trials were conducted and showed statistically significant benefits of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) over placebo. Meanwhile, critics are increasing regarding the efficacy of antidepressants in the treatment of MDD because at least a proportion of clinical trials could be hampered by various biases. In contrast, number of failed trials is increasing in the recent years which have made developing psychiatric medications progressively more time-consuming and expensive. Areas covered: Biases and related issues in clinical trials for antidepressants can be identified as an important common contributing factor to the two paradoxical phenomenon. This review identifies possible biases that can occur before, during, and after clinical trials of antidepressant. Expert commentary: Recent studies not only may over-estimate efficacy of antidepressants, but also may exaggerate placebo response because of various biases. Sponsorship and publication biases have been one of the targets of the criticism and ethical debate. Thus, initiating new trend of research by re-organizing academic-industry partnership will be the most important task in the next five years.

Overview

Integrity signals

Registry

Crossref · 10.1080/17512433.2017.1377070

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 90 references

Research works printed but not linked: 5

  1. 10.1192/bjp.183.6.498 · doi:10.1192/bjp.183.6.498 · Paper page
  2. Kirsch I, 2014, Z Psychol, 222, 128
  3. Stettin GD, 2006, Am J Manag Care, 12, 453
  4. Bass MJ, 1986, J Fam Pract, 23, 43
  5. Friedman JH, 2004, Med Health R I, 87, 262

Cited by

See all 20

Metadata

Authors
Wang, S.-M., Han, C., Lee, S.-J., Jun, T.-Y., Patkar, A. A., Masand, P. S., & Pae, C.-U.
Affiliations
  • The Catholic University of Korea Seoul St. Mary's Hospital (KR)
  • Korea University (KR)
  • Catholic University of Korea (KR)
  • Duke Medical Center (US)
  • Global Medical Education, New York, NY, USA
Corresponding author
Pae, Chi-Un
Venue
Expert Review of Clinical Pharmacology
Published
2017-09-14
Volume
11
Issue
1
Pages
15-25
ISSN
  • 1751-2433 (ISSN-L)
  • 1751-2441
OpenAlex
W2754151110
Cited by
20
References
90
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2019: 7 · 2018: 3
FWCI
0.35
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (HC15C1405)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords
antidepressants, antidepressant efficacy, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, major depressive disorder, trial bias, placebo response, publication bias, sponsorship bias, university-industry collaboration, clinical trial failure, psychiatric drug development
MeSH terms
Serotonin and Noradrenaline Reuptake Inhibitors, Antidepressive Agents, Major Depressive Disorder, Humans, Bias, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Publication Bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of antidepressants: bias in randomized clinical trials and related issues. https://app.cochat.ai/papers/10.1080/17512433.2017.1377070
The paper
Wang, S.-M., Han, C., Lee, S.-J., Jun, T.-Y., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018). Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2017.1377070

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.